Fingerprint
Dive into the research topics of 'Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients
Qingsong Zhu, Evgeny Izumchenko, Alexander M. Aliper, Evgeny Makarev, Keren Paz, Anton A. Buzdin, Alex A. Zhavoronkov, David Sidransky
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations